標題: Titlebook: Gene Therapy and Cell Therapy Through the Liver; Current Aspects and Shuji Terai,Takeshi Suda Book 2016 Springer Japan 2016 CPC Isolator.a [打印本頁] 作者: 連結(jié) 時間: 2025-3-21 16:44
書目名稱Gene Therapy and Cell Therapy Through the Liver影響因子(影響力)
書目名稱Gene Therapy and Cell Therapy Through the Liver影響因子(影響力)學科排名
書目名稱Gene Therapy and Cell Therapy Through the Liver網(wǎng)絡公開度
書目名稱Gene Therapy and Cell Therapy Through the Liver網(wǎng)絡公開度學科排名
書目名稱Gene Therapy and Cell Therapy Through the Liver被引頻次
書目名稱Gene Therapy and Cell Therapy Through the Liver被引頻次學科排名
書目名稱Gene Therapy and Cell Therapy Through the Liver年度引用
書目名稱Gene Therapy and Cell Therapy Through the Liver年度引用學科排名
書目名稱Gene Therapy and Cell Therapy Through the Liver讀者反饋
書目名稱Gene Therapy and Cell Therapy Through the Liver讀者反饋學科排名
作者: Spinous-Process 時間: 2025-3-21 23:41
Macrophage Therapy for Liver Fibrosis and Regenerationjury both the resident macrophages and circulating monocytes influence both liver regeneration and liver fibrosis. Kupffer cells can stimulate hepatocyte proliferation via the secretion of IL-6; macrophages stimulate a ductular proliferation via TWEAK secretion and also secrete Wnts which stimulate 作者: infringe 時間: 2025-3-22 01:04 作者: MINT 時間: 2025-3-22 06:39
Novel Immunotherapy Using Liver-Derived Natural Killer Cells for Preventing Hepatocellular Carcinomaants. However, no prevention or treatment exists for HCC recurrence after liver transplantation. Here, we describe an adoptive immunotherapy approach that uses natural killer (NK) cells derived from both living and deceased donor liver graft perfusates. Liver NK cells exhibited the vigorous cytotoxi作者: hedonic 時間: 2025-3-22 12:46 作者: voluble 時間: 2025-3-22 16:34 作者: voluble 時間: 2025-3-22 19:10
Potential Usage of Human Artificial Chromosome for Regenerative Medicineneered creation) or a “bottom-up approach” (de novo creation). HACs with one or more acceptor sites exhibit several characteristics required by an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci plus their regulatory elements, thus allow作者: antecedence 時間: 2025-3-22 21:28
Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applicationsn its cells. Conventional therapeutic methods are often insufficient or unavailable to manage genetic diseases in the liver; therefore, more efficient strategies are urgently needed. Gene therapy emerged as novel method of treatment relying on liver-directed transfer of a gene-coding sequence to pro作者: bioavailability 時間: 2025-3-23 03:52 作者: FLAGR 時間: 2025-3-23 06:48 作者: Deduct 時間: 2025-3-23 11:32 作者: 劇毒 時間: 2025-3-23 16:46
Critical Path Initiative for Regenerative Medicine in Japangenerative Medicine) was enacted in April and enforced in May 2013, and the enforcement of the Act led to the Act Concerning Safety Assurance of Regenerative Medicine (Act on the Safety of Regenerative Medicine) and the Revised Pharmaceutical Affairs Law (Pharmaceuticals and Medical Devices Law) (en作者: MIRTH 時間: 2025-3-23 19:44
Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technologyted from entering the product. It has been recognized for decades, and humans working in aseptic environments were the only significant source of contamination and therefore posed the greatest risk to both successful production of heat-labile products and to the patient. Over the last two decades, t作者: enmesh 時間: 2025-3-23 22:19
Cell and Vector Production Facility for Gene Therapy and Cell Therapy0 years. However, Japan shows a remarkable delay compared with the West in the clinical application of gene therapy, and one reason is that organizations manufacturing bioproducts for conducting high-quality clinical studies have not been fully established in Japan. Recently, the Japanese government作者: 全部逛商店 時間: 2025-3-24 03:38
https://doi.org/10.1007/978-4-431-55666-4CPC Isolator; adeno-associated virus (AAV); immunotherapy; legal regulation; liver fibrosis; regeneration作者: Conserve 時間: 2025-3-24 08:53 作者: 蟄伏 時間: 2025-3-24 14:01
https://doi.org/10.1007/978-1-349-03819-0actory, and thus, efficient therapeutic approaches have always been in need. In parallel with recent advances in molecular biology and recombinant DNA technologies, research in liver diseases and the quest for molecular insights of disease pathology have witnessed remarkable progression, and early a作者: PATRI 時間: 2025-3-24 15:09
Civilized Oppression and Moral Relationsjury both the resident macrophages and circulating monocytes influence both liver regeneration and liver fibrosis. Kupffer cells can stimulate hepatocyte proliferation via the secretion of IL-6; macrophages stimulate a ductular proliferation via TWEAK secretion and also secrete Wnts which stimulate 作者: insidious 時間: 2025-3-24 19:58
Groundwater Cladocera: A synopsislated BMCs produce collagenases including matrix metalloproteinase-9. As a result, we observed reduced liver fibrosis, elevated serum albumin levels, and a significant increase in survival. Based on these data, we have begun “autologous bone marrow cell infusion (ABM.) therapy” using non-cultured au作者: adjacent 時間: 2025-3-24 23:24 作者: 窗簾等 時間: 2025-3-25 06:17 作者: Bmd955 時間: 2025-3-25 08:32
https://doi.org/10.1007/978-3-8348-9690-2ease therapy are promising. Numerous attempts are ongoing for this purpose. One of the most prominent examples is the sustained clinical benefit in hemophilia gene therapy targeting the liver. These successes have been brought chiefly by the progress in vectorology, especially capsid development. At作者: originality 時間: 2025-3-25 14:45
https://doi.org/10.1007/978-3-322-97806-6neered creation) or a “bottom-up approach” (de novo creation). HACs with one or more acceptor sites exhibit several characteristics required by an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci plus their regulatory elements, thus allow作者: 讓空氣進入 時間: 2025-3-25 17:47
Anwendungsbereiche der Optionspreistheorie,n its cells. Conventional therapeutic methods are often insufficient or unavailable to manage genetic diseases in the liver; therefore, more efficient strategies are urgently needed. Gene therapy emerged as novel method of treatment relying on liver-directed transfer of a gene-coding sequence to pro作者: 彎腰 時間: 2025-3-25 23:42 作者: 完整 時間: 2025-3-26 01:27
https://doi.org/10.1007/978-3-319-31086-2n the European Union, has been made with Regulation 1394/2007/EC. By this regulation a new committee, the Committee for Advanced Therapies, has been established to ensure appropriate coverage of scientific and regulatory aspects of ATMPs. In addition, novel regulatory tools specific for ATMPs such a作者: 民間傳說 時間: 2025-3-26 07:19
https://doi.org/10.1007/978-3-319-71350-2also careful consideration of a variety of issues that include accessing tissue in an ethically appropriate fashion and adhering to the current rules and regulations for specific local, national, and international jurisdictions, which, if not harmonized, will likely hinder progress. Countries have d作者: obstruct 時間: 2025-3-26 08:51 作者: clarify 時間: 2025-3-26 12:45
4-Phosphoerythronate dehydogenase,ted from entering the product. It has been recognized for decades, and humans working in aseptic environments were the only significant source of contamination and therefore posed the greatest risk to both successful production of heat-labile products and to the patient. Over the last two decades, t作者: Pageant 時間: 2025-3-26 19:01
https://doi.org/10.1007/978-3-540-85699-30 years. However, Japan shows a remarkable delay compared with the West in the clinical application of gene therapy, and one reason is that organizations manufacturing bioproducts for conducting high-quality clinical studies have not been fully established in Japan. Recently, the Japanese government作者: Introvert 時間: 2025-3-27 00:17
https://doi.org/10.1007/978-1-349-03819-0ls to generate curative effects. Gene therapy comprises various methods of gene delivery and innovative overexpression and silencing designs for specific therapeutic needs (Kay MA, Nat Rev Genet 12:316–328, 2011). Cell-based therapies, on the other hand, aim to use biologically active living cells i作者: Progesterone 時間: 2025-3-27 04:28
Groundwater Cladocera: A synopsis hepatic fibrosis in immunodeficient cirrhotic mice, consistent with the maintenance of redox homeostasis in hepatic stellate cells and hepatocytes. To evaluate safety using canine models, cultured autologous MSCs were administered to the same subject in approximately three times the quantity and te作者: Exuberance 時間: 2025-3-27 05:47 作者: 護航艦 時間: 2025-3-27 11:28
Anwendungsbereiche der Optionspreistheorie,drodynamic gene delivery is among the most efficient and the most commonly used method for liver-directed gene delivery. Here we will briefly summarize the principles and the progress that have been made in hydrodynamic gene delivery toward clinical applications.作者: bile648 時間: 2025-3-27 17:00 作者: 姑姑在炫耀 時間: 2025-3-27 19:26 作者: armistice 時間: 2025-3-27 22:03 作者: Astigmatism 時間: 2025-3-28 05:41 作者: resistant 時間: 2025-3-28 06:16
https://doi.org/10.1007/978-3-540-85699-3erapy as a CDMO (Contract Development and Manufacturing Organization), which provides clients with comprehensive services from drug development through manufacture, based not only on Japanese GMP but also on cGMP, EU GMP, and other related regulations and on the Cartagena Act to prevent the dispersa作者: Amendment 時間: 2025-3-28 14:12 作者: 得體 時間: 2025-3-28 17:47
Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients hepatic fibrosis in immunodeficient cirrhotic mice, consistent with the maintenance of redox homeostasis in hepatic stellate cells and hepatocytes. To evaluate safety using canine models, cultured autologous MSCs were administered to the same subject in approximately three times the quantity and te作者: 橫條 時間: 2025-3-28 18:51 作者: circumvent 時間: 2025-3-29 00:36
Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applicationsdrodynamic gene delivery is among the most efficient and the most commonly used method for liver-directed gene delivery. Here we will briefly summarize the principles and the progress that have been made in hydrodynamic gene delivery toward clinical applications.作者: Gossamer 時間: 2025-3-29 04:57 作者: dapper 時間: 2025-3-29 08:07 作者: Limousine 時間: 2025-3-29 11:57 作者: Exclude 時間: 2025-3-29 15:48 作者: 玩笑 時間: 2025-3-29 23:42
Cell and Vector Production Facility for Gene Therapy and Cell Therapyerapy as a CDMO (Contract Development and Manufacturing Organization), which provides clients with comprehensive services from drug development through manufacture, based not only on Japanese GMP but also on cGMP, EU GMP, and other related regulations and on the Cartagena Act to prevent the dispersa
